The U.S. Food and Drug Administration (FDA) has given approval to the Gilead AIDS drug Viread, to help treat hepatitis B patients. The Gilead AIDS drug is known in its generic form as tenofovir, and has been on the market as an AIDS drug since 2001. Recent studies though have shown that it is very effective in treating people who are living with hepatitis B, helping by controlling the disease. Hepatitis B can be a fatal disease, attacking the liver.

Related Information

• Viread - Another Med to Fight the Battle

• Viread Fact Sheet

• HIV Treatment Regimens

The Beijing Olympics are finally here and with them the human interest stories of the Games and their athletes. One of those human interest stories has an HIV connection. Olympic Diving Champion Greg Louganis has a unique story of courage and overcoming adversity; both in and out of the pool. Here is the story of Greg Louganis.

Related Information

• CDC Recommendations for HIV Exposure

• HIV Post Exposure Prophylaxis

• Questions of HIV Transmission